Clinical Trials Directory

Trials / Terminated

TerminatedNCT02396251

Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation

A Multi-Centre, Evaluator-Blinded Study to Evaluate Efficacy and Safety of R Volumizer for Cheek Augmentation

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A multi-centre, evaluator-blinded study in subjects undergoing cheek augmentation. The study is designed to assess efficacy with regard to aesthetic midface augmentation and safety after treatment with HA product.

Conditions

Interventions

TypeNameDescription
DEVICEHA experimental
DEVICEHA comparator

Timeline

Start date
2015-02-28
Primary completion
2016-12-19
Completion
2017-11-14
First posted
2015-03-24
Last updated
2022-08-26
Results posted
2019-10-01

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02396251. Inclusion in this directory is not an endorsement.